Tavistock Investment - Further update re ongoing litigation with Titan

Tavistock Investments

17/12/2025 12:13

RNS Number : 9787L

Tavistock Investments PLC

17 December 2025

 

 

 

Tavistock Investments Plc

("Tavistock" or the "Company")

 

17 December 2025 

 

 

FURTHER UPDATE RE ONGOING LITIGATION WITH TITAN

 

Response to statement made by Titan

 

 

Tavistock issued an announcement yesterday to update the market on the outcome of the Court hearing held on 11 December 2025 in relation to its dispute with Titan. In response Titan stated: "We respect the court's decision that, procedurally, the defendants have satisfied the low threshold required to introduce into their pleading the amendments Titan has been contesting. Titan nevertheless maintains that the defendants' counterclaims are factually and legally flawed and are likely to fail at the trial, which remains listed to take place in the summer of 2027."

 

A spokesman for Tavistock has today commented:

 

"If the threshold was low to introduce our pleadings which are factually and legally flawed and likely to fail at trial, why would Titan spend hundreds of thousands of pounds trying to prevent them being included?"

 

 

For further information:

 

Tavistock Investments Plc
Oliver Cooke
Brian Raven
Tel: 01753 867000
Allenby Capital Limited
(Nominated adviser and broker)
Corporate Finance:
Nick Naylor, Nick Athanas
Sales and Corporate Broking:
Tony Quirke
Tel: 020 3328 5656
Flagstaff Communications
(Financial PR/IR)
Tim Thompson
Alison Allfrey
Anna Probert
tavistock@flagstaffcomms.com
Tel: 0207 129 1474

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

 
  END

 

 
RSPGZMMZZNNGKZM